Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
life sciences
national
national blog main
national top stories
novartis
5
×
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
biogen
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
clinical trials
ipo
vc
venture capital
abbvie
crispr
deerfield management
democrats
europe blog main
What
ipo
5
×
bio
roundup
biogen
cancer
covid
developing
investors
medicines
new
public
years
acquisitions
activity
allogene
america
announced
approvals
blood
broader
ceo
clamped
collabs
company
continues
convoluted
crispr
daniel
deal
delays
democrats
detect
diversity
dreams
economic
fast
fda
files
firms
gilead
Language
unset
Current search:
ipo
×
novartis
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More